 Sarah Jolley
Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 12 | 2025 | 916 | 3.120 |
Why?
| | Alcoholism | 6 | 2025 | 817 | 1.460 |
Why?
| | Psychotic Disorders | 5 | 2021 | 186 | 1.390 |
Why?
| | Critical Illness | 8 | 2024 | 891 | 1.360 |
Why?
| | Occupational Therapy | 2 | 2022 | 111 | 1.000 |
Why?
| | Patient Admission | 2 | 2025 | 218 | 0.980 |
Why?
| | Early Ambulation | 2 | 2017 | 25 | 0.930 |
Why?
| | Pneumonia | 4 | 2023 | 631 | 0.920 |
Why?
| | Survivors | 4 | 2025 | 520 | 0.880 |
Why?
| | Physical Therapy Modalities | 3 | 2017 | 332 | 0.770 |
Why?
| | Child Behavior | 2 | 2015 | 236 | 0.760 |
Why?
| | Problem Behavior | 1 | 2023 | 102 | 0.700 |
Why?
| | Mobility Limitation | 2 | 2019 | 66 | 0.690 |
Why?
| | Respiration, Artificial | 3 | 2017 | 708 | 0.690 |
Why?
| | Substance-Related Disorders | 3 | 2025 | 1094 | 0.660 |
Why?
| | Adolescent Health Services | 1 | 2021 | 75 | 0.650 |
Why?
| | Psychomotor Agitation | 1 | 2020 | 70 | 0.620 |
Why?
| | Adolescent Behavior | 2 | 2015 | 501 | 0.620 |
Why?
| | Aftercare | 2 | 2023 | 223 | 0.570 |
Why?
| | Patient Discharge | 3 | 2024 | 983 | 0.540 |
Why?
| | Cocaine-Related Disorders | 1 | 2019 | 132 | 0.520 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.510 |
Why?
| | Opioid-Related Disorders | 2 | 2023 | 600 | 0.510 |
Why?
| | Adult | 28 | 2026 | 40449 | 0.510 |
Why?
| | Fluid Therapy | 1 | 2017 | 147 | 0.480 |
Why?
| | Mental Health Services | 1 | 2021 | 473 | 0.470 |
Why?
| | Venous Thromboembolism | 1 | 2020 | 324 | 0.470 |
Why?
| | Life Support Care | 1 | 2016 | 40 | 0.460 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2016 | 98 | 0.450 |
Why?
| | Marijuana Use | 1 | 2019 | 213 | 0.450 |
Why?
| | Hospitalization | 9 | 2025 | 2433 | 0.450 |
Why?
| | Humans | 52 | 2026 | 144759 | 0.440 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.440 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.440 |
Why?
| | Bullying | 1 | 2015 | 44 | 0.440 |
Why?
| | Middle Aged | 22 | 2026 | 35875 | 0.430 |
Why?
| | Hospitals, Teaching | 1 | 2015 | 119 | 0.430 |
Why?
| | Adolescent Development | 1 | 2015 | 72 | 0.420 |
Why?
| | HIV Infections | 3 | 2019 | 3154 | 0.410 |
Why?
| | Extracorporeal Membrane Oxygenation | 3 | 2023 | 383 | 0.410 |
Why?
| | Neuromuscular Diseases | 1 | 2016 | 146 | 0.410 |
Why?
| | Self Concept | 1 | 2015 | 253 | 0.400 |
Why?
| | Crime Victims | 1 | 2015 | 129 | 0.390 |
Why?
| | Clinical Protocols | 1 | 2015 | 282 | 0.390 |
Why?
| | Family Therapy | 1 | 2013 | 67 | 0.380 |
Why?
| | Alcohol Drinking | 2 | 2019 | 826 | 0.380 |
Why?
| | Activities of Daily Living | 3 | 2023 | 441 | 0.380 |
Why?
| | Retrospective Studies | 16 | 2025 | 17066 | 0.380 |
Why?
| | Female | 30 | 2026 | 78271 | 0.380 |
Why?
| | Prevalence | 6 | 2025 | 2834 | 0.360 |
Why?
| | Male | 28 | 2026 | 72315 | 0.360 |
Why?
| | Louisiana | 2 | 2024 | 28 | 0.340 |
Why?
| | Aged | 14 | 2026 | 25913 | 0.330 |
Why?
| | Motor Activity | 1 | 2015 | 721 | 0.310 |
Why?
| | Cognition | 3 | 2023 | 1266 | 0.310 |
Why?
| | Child Development | 1 | 2015 | 484 | 0.310 |
Why?
| | Cohort Studies | 9 | 2025 | 5960 | 0.300 |
Why?
| | Length of Stay | 3 | 2020 | 1337 | 0.270 |
Why?
| | Referral and Consultation | 1 | 2014 | 851 | 0.270 |
Why?
| | Multicenter Studies as Topic | 3 | 2023 | 405 | 0.260 |
Why?
| | Weight Gain | 1 | 2011 | 556 | 0.250 |
Why?
| | Ethanol | 2 | 2022 | 627 | 0.250 |
Why?
| | United States | 8 | 2025 | 15966 | 0.240 |
Why?
| | Adolescent | 11 | 2025 | 22428 | 0.240 |
Why?
| | Attitude of Health Personnel | 1 | 2014 | 1185 | 0.240 |
Why?
| | Transcranial Direct Current Stimulation | 1 | 2026 | 6 | 0.240 |
Why?
| | Prospective Studies | 8 | 2025 | 7990 | 0.240 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 326 | 0.230 |
Why?
| | Colorado | 3 | 2025 | 4564 | 0.220 |
Why?
| | Washington | 2 | 2015 | 147 | 0.210 |
Why?
| | Multivariate Analysis | 2 | 2019 | 1539 | 0.200 |
Why?
| | Hand Strength | 1 | 2024 | 144 | 0.200 |
Why?
| | Hospital Mortality | 2 | 2025 | 1030 | 0.190 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5868 | 0.190 |
Why?
| | Cognitive Dysfunction | 2 | 2026 | 461 | 0.190 |
Why?
| | Longitudinal Studies | 3 | 2025 | 2947 | 0.190 |
Why?
| | Body Mass Index | 1 | 2011 | 2438 | 0.180 |
Why?
| | Telerehabilitation | 1 | 2022 | 43 | 0.180 |
Why?
| | Child | 5 | 2023 | 22633 | 0.170 |
Why?
| | Quality of Life | 4 | 2023 | 3185 | 0.170 |
Why?
| | Critical Care | 3 | 2024 | 695 | 0.170 |
Why?
| | Central Nervous System Depressants | 1 | 2021 | 83 | 0.170 |
Why?
| | Severity of Illness Index | 3 | 2019 | 2925 | 0.170 |
Why?
| | Naltrexone | 1 | 2022 | 117 | 0.170 |
Why?
| | Risk Factors | 4 | 2024 | 10779 | 0.160 |
Why?
| | Nursing Assessment | 1 | 2020 | 56 | 0.160 |
Why?
| | School Health Services | 1 | 2023 | 224 | 0.160 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2022 | 248 | 0.150 |
Why?
| | Schools | 1 | 2023 | 453 | 0.150 |
Why?
| | Mobile Applications | 1 | 2022 | 196 | 0.150 |
Why?
| | Patient Acceptance of Health Care | 2 | 2025 | 885 | 0.150 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2021 | 186 | 0.150 |
Why?
| | Exercise | 1 | 2011 | 2201 | 0.140 |
Why?
| | Tobacco Smoking | 1 | 2018 | 26 | 0.140 |
Why?
| | Frailty | 1 | 2022 | 198 | 0.140 |
Why?
| | Pandemics | 3 | 2023 | 1694 | 0.140 |
Why?
| | Tobacco Use | 1 | 2018 | 61 | 0.140 |
Why?
| | Decision Making | 1 | 2025 | 975 | 0.130 |
Why?
| | Tobacco Products | 1 | 2018 | 84 | 0.130 |
Why?
| | Emotions | 1 | 2023 | 578 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 545 | 0.130 |
Why?
| | Antiretroviral Therapy, Highly Active | 1 | 2019 | 278 | 0.130 |
Why?
| | Substance Abuse, Intravenous | 1 | 2019 | 128 | 0.130 |
Why?
| | National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 103 | 0.130 |
Why?
| | Markov Chains | 1 | 2017 | 129 | 0.130 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2019 | 636 | 0.130 |
Why?
| | Nontuberculous Mycobacteria | 1 | 2019 | 208 | 0.130 |
Why?
| | Community-Acquired Infections | 1 | 2019 | 174 | 0.120 |
Why?
| | Linear Models | 1 | 2019 | 854 | 0.120 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1720 | 0.120 |
Why?
| | Muscular Diseases | 1 | 2017 | 108 | 0.120 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2016 | 40 | 0.120 |
Why?
| | Curriculum | 1 | 2023 | 1059 | 0.120 |
Why?
| | Alcohol-Related Disorders | 1 | 2017 | 120 | 0.110 |
Why?
| | Health Facility Size | 1 | 2015 | 13 | 0.110 |
Why?
| | Delivery of Health Care | 1 | 2022 | 947 | 0.110 |
Why?
| | Hospitals, Low-Volume | 1 | 2015 | 25 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 710 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2023 | 893 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 865 | 0.110 |
Why?
| | Hospitals, High-Volume | 1 | 2015 | 49 | 0.110 |
Why?
| | Internal-External Control | 1 | 2015 | 75 | 0.110 |
Why?
| | Homosexuality, Male | 1 | 2016 | 222 | 0.110 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2019 | 366 | 0.100 |
Why?
| | Comorbidity | 1 | 2019 | 1658 | 0.100 |
Why?
| | Aggression | 1 | 2015 | 179 | 0.100 |
Why?
| | Physical Therapists | 1 | 2014 | 64 | 0.100 |
Why?
| | Logistic Models | 2 | 2017 | 2117 | 0.100 |
Why?
| | Pilot Projects | 2 | 2022 | 1886 | 0.100 |
Why?
| | Sex Factors | 1 | 2019 | 2112 | 0.090 |
Why?
| | Telemedicine | 1 | 2022 | 945 | 0.090 |
Why?
| | Tracheostomy | 1 | 2014 | 142 | 0.090 |
Why?
| | Schizophrenic Psychology | 1 | 2012 | 97 | 0.090 |
Why?
| | Nurses | 1 | 2014 | 178 | 0.090 |
Why?
| | Data Collection | 1 | 2014 | 633 | 0.090 |
Why?
| | Young Adult | 4 | 2025 | 14105 | 0.090 |
Why?
| | Psychometrics | 1 | 2015 | 734 | 0.080 |
Why?
| | Surveys and Questionnaires | 2 | 2014 | 6048 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2018 | 1173 | 0.080 |
Why?
| | Attitude to Health | 1 | 2012 | 436 | 0.070 |
Why?
| | Schizophrenia | 1 | 2012 | 446 | 0.070 |
Why?
| | Energy Intake | 1 | 2011 | 499 | 0.070 |
Why?
| | Emergency Service, Hospital | 1 | 2018 | 2310 | 0.060 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1795 | 0.060 |
Why?
| | Time Factors | 1 | 2017 | 7173 | 0.060 |
Why?
| | Child, Preschool | 1 | 2021 | 11787 | 0.060 |
Why?
| | Physicians | 1 | 2014 | 939 | 0.060 |
Why?
| | Risk Assessment | 1 | 2015 | 3671 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2026 | 11679 | 0.050 |
Why?
| | Viral Load | 1 | 2025 | 526 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2023 | 129 | 0.050 |
Why?
| | Fatigue | 1 | 2023 | 366 | 0.040 |
Why?
| | Rural Population | 1 | 2025 | 650 | 0.040 |
Why?
| | New Orleans | 1 | 2018 | 15 | 0.040 |
Why?
| | Needs Assessment | 1 | 2021 | 404 | 0.040 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 2019 | 130 | 0.030 |
Why?
| | Interleukin-6 | 1 | 2022 | 780 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2022 | 1095 | 0.030 |
Why?
| | Age Distribution | 1 | 2018 | 403 | 0.030 |
Why?
| | Sex Distribution | 1 | 2018 | 386 | 0.030 |
Why?
| | Qualitative Research | 1 | 2025 | 1671 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.030 |
Why?
| | Sputum | 1 | 2019 | 308 | 0.030 |
Why?
| | Tidal Volume | 1 | 2017 | 111 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2025 | 3604 | 0.030 |
Why?
| | Societies, Medical | 1 | 2021 | 887 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2022 | 600 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2025 | 1414 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2024 | 1519 | 0.030 |
Why?
| | Selectins | 1 | 2016 | 8 | 0.030 |
Why?
| | Angiopoietin-1 | 1 | 2016 | 12 | 0.030 |
Why?
| | Angiopoietin-2 | 1 | 2016 | 15 | 0.030 |
Why?
| | Machine Learning | 1 | 2022 | 585 | 0.030 |
Why?
| | Bronchoalveolar Lavage | 1 | 2016 | 89 | 0.030 |
Why?
| | Urban Population | 1 | 2018 | 491 | 0.030 |
Why?
| | Anxiety | 1 | 2023 | 1109 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2847 | 0.030 |
Why?
| | Vaccination | 1 | 2024 | 1423 | 0.030 |
Why?
| | Mental Health | 1 | 2022 | 790 | 0.030 |
Why?
| | Quality Improvement | 1 | 2021 | 1289 | 0.020 |
Why?
| | Secondary Prevention | 1 | 2012 | 254 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2878 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1990 | 64 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2012 | 541 | 0.020 |
Why?
| | Neurofibromatosis 1 | 1 | 1990 | 54 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1306 | 0.020 |
Why?
| | Genetic Markers | 1 | 1990 | 331 | 0.020 |
Why?
| | Lung | 1 | 2022 | 4109 | 0.020 |
Why?
| | DNA | 1 | 1990 | 1463 | 0.010 |
Why?
| | Animals | 1 | 2017 | 38058 | 0.010 |
Why?
| | Genetic Carrier Screening | 1 | 1990 | 32 | 0.010 |
Why?
| | Lod Score | 1 | 1990 | 62 | 0.010 |
Why?
| | DNA Probes | 1 | 1990 | 59 | 0.000 |
Why?
| | Genetic Linkage | 1 | 1990 | 273 | 0.000 |
Why?
| | Pedigree | 1 | 1990 | 514 | 0.000 |
Why?
| | Alleles | 1 | 1990 | 879 | 0.000 |
Why?
|
|
Jolley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|